ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the tr…
Biotechnology
US, San Diego [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2024 | 2 | $8,000,000 | LD-2 : 07/14/24 |
| 2024 | 1 | $1,000,000 | LD-2 : 04/19/24 |
| 2024 | 1 | $8,000,000 | LD-2 : 04/12/24 |
| 2023 | 4 | $1,000,000 | LD-2 : 01/22/24 |
| 2023 | 4 | $8,000,000 | LD-2 : 01/13/24 |
Get PRO Today
With PRO you will unlock 3 more lobbying disclosures for ACADIA Pharmaceuticals Inc.